Serotonin 5-HT1 Receptor Agonists
"Serotonin 5-HT1 Receptor Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes.
| Descriptor ID |
D058825
|
| MeSH Number(s) |
D27.505.519.625.850.800.100 D27.505.696.577.850.800.100
|
| Concept/Terms |
Serotonin 5-HT1 Receptor Agonists- Serotonin 5-HT1 Receptor Agonists
- Serotonin 5 HT1 Receptor Agonists
- 5-HT1 Agonist
- 5 HT1 Agonist
- Agonist, 5-HT1
- 5-HT1 Agonists
- 5 HT1 Agonists
- Agonists, 5-HT1
Serotonin 5-HT1B-D Agonists- Serotonin 5-HT1B-D Agonists
- 5-HT1B-D Agonists, Serotonin
- Agonists, Serotonin 5-HT1B-D
- Serotonin 5 HT1B D Agonists
- 5-HT1B-D Agonist
- 5 HT1B D Agonist
- Agonist, 5-HT1B-D
|
Below are MeSH descriptors whose meaning is more general than "Serotonin 5-HT1 Receptor Agonists".
Below are MeSH descriptors whose meaning is more specific than "Serotonin 5-HT1 Receptor Agonists".
This graph shows the total number of publications written about "Serotonin 5-HT1 Receptor Agonists" by people in this website by year, and whether "Serotonin 5-HT1 Receptor Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Serotonin 5-HT1 Receptor Agonists" by people in Profiles.
-
Johnson-Agbakwu C, Brown L, Yuan J, Kissling R, Greenblatt DJ. Effects of Flibanserin on the Pharmacokinetics of a Combined Ethinylestradiol/Levonorgestrel Oral Contraceptive in Healthy Premenopausal Women: A Randomized Crossover Study. Clin Ther. 2018 01; 40(1):64-73.
-
Wood ME, Lapane K, Frazier JA, Ystrom E, Mick EO, Nordeng H. Prenatal Triptan Exposure and Internalising and Externalising Behaviour Problems in 3-Year-Old Children: Results from the Norwegian Mother and Child Cohort Study. Paediatr Perinat Epidemiol. 2016 Mar; 30(2):190-200.
-
Piper BJ, Vu HL, Safain MG, Oliver AJ, Meyer JS. Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist. J Pharmacol Exp Ther. 2006 May; 317(2):838-49.